Travel Medicine Advisor Archives – February 1, 2012

February 1, 2012

• Childproof: Meningococcal Vaccine for Very Young At-Risk Travelers

  The Advisory Committee on Immunization Practices (ACIP) set forth new guidelines in October 2011 for the use of a quadrivalent meningococcal conjugate vaccine (MenACWY-D) in children, ages 9 to 23 months, that are at increased risk for meningococcal disease.

  Read more

• Isoniazid and Rifapentine for Treatment of Latent Tuberculosis

  In this report, the new CDC recommendations for the concomitant use of isoniazid (INH) and rifapentine (RPT) administered weekly for 12 weeks as directly observed therapy (DOT) are detailed.

  Read more

• ID Symptoms in Immune Suppressed Travelers

  Investigators from The Netherlands conducted a prospective study to assess whether short-term travelers on immunosuppressive agents (ISA) or those with inflammatory bowel disease (IBD) had increased risk of infectious diseases compared to matched controls.

  Read more

• Advice Ignored on Acute Mountain Sickness

  Acute mountain sickness (AMS) is a syndrome that can affect travelers who are not acclimatized and gain altitude too quickly, usually occurring above 2,500 m. (8,200 ft.) elevation.

  Read more

• Pharmacology Watch: New, Shorter Treatment Regimen for Tuberculosis

  In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions.

  Read more